Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study

CONCLUSIONS: Teneligliptin 20 mg could be considered as the preferred and most cost-effective agent among commonly used DPP4Is for the effective management of patients with T2DM in India.PMID:37232153 | DOI:10.1080/17446651.2023.2216279

Source: Expert Review of Endocrinology and Metabolism - May 26, 2023 Category: Endocrinology Authors: Harmanjit Singh Ekta Arora Seerat Narula Mandeep Singla Armaan Otaal Jatin Sharma Source Type: research